NPI: 1316473846 · FORT COLLINS, CO 80524 · Primary Care Clinic/Center · NPI assigned 05/03/2017
Authorized official RAGER, REBECCA controls 20+ related entities in our dataset. Read more
| Authorized Official | RAGER, REBECCA (DIRECTOR REVENUE CYCLE) |
| Parent Organization | VMD PRIMARY PROVIDERS COLORADO, INC |
| NPI Enumeration Date | 05/03/2017 |
Other providers sharing the same authorized official: RAGER, REBECCA
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 1,660 | $75K |
| 2022 | 1,549 | $81K |
| 2023 | 4,474 | $62K |
| 2024 | 2,493 | $27K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,777 | 2,434 | $143K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,220 | 961 | $83K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 263 | 253 | $12K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 192 | 185 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 132 | 62 | $2K |
| 90686 | 90 | 87 | $999.14 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 34 | 31 | $962.68 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 12 | 12 | $198.36 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 265 | 246 | $2.45 |
| 3074F | 1,100 | 965 | $0.00 | |
| 3008F | 454 | 403 | $0.00 | |
| 1036F | 515 | 439 | $0.00 | |
| 1000F | 143 | 116 | $0.00 | |
| 1126F | 64 | 55 | $0.00 | |
| 1125F | 16 | 12 | $0.00 | |
| 3079F | 17 | 13 | $0.00 | |
| 3078F | 685 | 605 | $0.00 | |
| 1160F | 865 | 762 | $0.00 | |
| 1159F | 865 | 762 | $0.00 | |
| 3725F | 467 | 432 | $0.00 |